Matthias Bodenstedt Moon Lake Immunotherapeutics (MLTX) insider trading activity
Matthias Bodenstedt is Chief Financial Officer of MoonLake Immunotherapeutics. Currently has a direct ownership of 616,666 shares of MLTX, which is worth approximately $25.8 Million. The most recent transaction as insider was on Feb 27, 2025, when has been sold 95,763 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
617K
18.38%
3M change
18.38%
12M change
Total Value Held
$25.8 Million
Matthias Bodenstedt Transaction History
MB
Matthias Bodenstedt
Chief Financial Officer
Zug, V8